GlassScriptPhysician profile
Sabrina Coffman
NPI 1528406345
$4,920.46
in general payments reported to CMS, 2019-2025
44 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $673 · 2023: $1,274 · 2024: $1,273 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,827 · Education: $21.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,827.40 |
| Education | $21.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,207.47 | 2022-2025 | |
| Novo Nordisk INC | $722.09 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Biohaven Pharmaceuticals, INC. | $314.61 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $291.75 | 2023-2025 | Rexulti |
| Amgen INC. | $245.81 | 2022-2024 | Repatha, Otezla, Prolia |
| Astrazeneca Pharmaceuticals LP | $242.23 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $223.95 | 2021-2025 | Trelegy Ellipta |
| Ultragenyx Pharmaceutical INC. | $199.73 | 2021-2023 | |
| Lilly USA, LLC | $151.20 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $89.12 | 2022-2025 | Freestyle Libre 3, Freestyle Libre |
| Boston Scientific Corporation | $82.95 | 2023-2025 | Bodyguardian, Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $78.43 | 2022-2024 | |
| Exact Sciences Corporation | $76.40 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $74.10 | 2023-2024 | Spravato |
| Merz North America, INC. | $58.82 | 2023 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabrina Coffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.